A device for burning remaining blood for drug clinical trials

A technology for clinical trials and treatment devices, which is applied to the field of residual blood burning treatment devices for drug clinical trials, can solve the problems of poor sealing of blood collection tubes, exudation of residual blood, unpleasant odor, etc., so as to improve burning efficiency and effect. , to prevent the growth of bacteria, the effect of prolonging the residence time

Active Publication Date: 2022-06-24
LUOYANG CENT HOSPITAL
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] 1) The blood collection tube is not tightly sealed, resulting in leakage of remaining blood and affecting the environment;
[0006] 2) After being stored for a long time in the warehouse, the remaining blood will deteriorate and the smell will be very unpleasant, especially in summer when the temperature is high;

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A device for burning remaining blood for drug clinical trials
  • A device for burning remaining blood for drug clinical trials
  • A device for burning remaining blood for drug clinical trials

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] like figure 1 and 2 As shown in the figure, a residual blood burning treatment device for clinical trials of medicines includes a closed cylindrical case 1, and the cylindrical case 1 is divided into an upper residual blood adsorption chamber 102 and a lower burning treatment chamber 103, wherein, the residual blood adsorption cavity 102 is filled with the storage material 3 for adsorbing the residual blood, the top of the residual blood adsorption cavity 102 has a residual blood pouring port 101 into which residual blood is poured, and the residual blood pouring port 101 has a remnant blood pouring port 101. The open cover plate is inclined at the bottom, and a discharge port 108 for discharging the storage material to the burning treatment chamber 103 is provided at the lowest position. The discharge port 108 has a valve plate controlled by a solenoid valve, which is controlled by the PLC intelligent controller to open and Closed, a screen 1011 is inclined below the ...

Embodiment 2

[0041] This embodiment is an improvement on the basis of Embodiment 1, and its main structure is the same as that of Embodiment 1. The improvement lies in: the storage material 3 is iron sand, porous ceramic particles, montmorillonite particles and Quicklime is formed by mixing in a mass ratio of 2:3:4:1, and the particle sizes of iron sand, porous ceramic particles and montmorillonite particles are all 1-3mm.

Embodiment 3

[0043] This embodiment is another improvement scheme made on the basis of Embodiment 1, and its main structure is the same as that of Embodiment 1. The improvement points are as follows: Figure 7 As shown, the lifting and dispersing mechanism 4 includes a rotating drum 401 driven by the power mechanism to rotate. The axis direction of the rotating drum 401 is parallel to the side of the screen 1011 and is the same length as the side of the screen 1011; The outer wall of the rotating drum 401 is distributed with at least three metal elastic dials 402 having the same length as the rotating drum 401. The distance between the movement track of the metal elastic dials 402 and the side wall of the screen 1011 is 1 cm, and the rotating drum 401 drives the metal elastic dials 402. During the clockwise rotation, the particles with large particle size or high speed in the storage material rolled down along the screen 1011 are lifted up by the metal elastic plate 402 and returned to the ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to view more

Abstract

A residual blood burning treatment device for drug clinical trials. The box is divided into an upper residual blood adsorption cavity and a lower burning treatment cavity. The residual blood adsorption cavity is filled with storage materials for absorbing residual blood. Among them, the remaining blood pouring port for pouring the remaining blood has an inclined bottom, and a discharge port for discharging the storage material to the burning treatment chamber is arranged at the lowest point, and a screen is arranged inclinedly below the discharge port in the burning treatment chamber. A lifting and dispersing mechanism is provided on the lower side of the screen, and a gas burner is provided under the screen. The present invention realizes the absorption and storage of residual blood by setting storage materials, and after accumulating for a period of time, burns the storage material that absorbs residual blood to carbonize, burn, and burn organic matter in residual blood The screen installed in the cavity cooperates with the lifting and dispersing mechanism, which can disperse the storage material that absorbs the remaining blood and solidifies, which improves the burning efficiency and effect, and saves energy.

Description

technical field [0001] The invention relates to the field of drug clinical trials, in particular to a residual blood burning treatment device for drug clinical trials. Background technique [0002] In drug clinical trials, it is often necessary to draw blood samples of volunteers after taking the drug for index testing. After blood samples are drawn, they need to be centrifuged to obtain serum and send it to a third-party testing agency for testing. The remaining blood samples are used clinically. Called "surplus blood", these residual blood generally have no test value and are handled by the clinical experiment center; [0003] Since the components of the residual blood are water and organic matter, if it is directly discharged into the sewer without treatment, it will become a "culture medium" for the growth of bacteria and germs; and the existing treatment method is generally, the residual blood is mixed with direct encapsulation. In the blood collection tube, it is treat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): B01D15/02B01D15/16B01D15/20B01D15/24B01D53/04B01D53/14B01D53/18B01J20/34B08B3/10F23G5/12F23G5/44F23G7/00
CPCB01D15/02B01D15/20B01D15/24B01D15/161B01J20/3433B01J20/3475B08B3/102F23G5/12F23G5/44F23G7/00B01D53/04B01D53/1437B01D53/18B01D2253/102B01D2253/116B01D2253/108B01D2258/02B01D2252/103
Inventor 李孟媛韩亚利李艳娜
Owner LUOYANG CENT HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap